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1034-212 5-Hydroxytryptamine 4 (5HT4) Receptor mRNA 
Processing in Favor of the 'b' Isoform Correlates With 
Left Atrial Dilatation and May Predispose to Atrial 
Fibrillation After Coronary Artery Bypass Grafting
Shamil Yusuf, Christiane Fenske, Chrysoula Delageorgou, Nicholas D. Carter, Naab Al 
Saady, Nidal Maarouf, A. John Camm, St. Georges Hospital Medical School, London, 
United Kingdom
BACKGROUND: 5HT, a novel hormonal trigger to AF, acts upon 5HT4 receptors on
human atrial myocytes which are linked to Gs proteins to increase heart rate. The role of
the various 5HT4 receptor isoforms in the pathogenesis of arrhythmias is not understood.
We postulated that expression of the 'a' and 'b' isoforms would correlate with left atrial
size and determine AF post CABG. METHODS: Right atrial appendage samples were
harvested from 47 patients undergoing bypass surgery. Pre operatively, a transthoracic
echocardiogram had been undertaken in all patients; their underlying heart rhythm was
documented and they were followed up after surgery until discharge. 21 patients main-
tained sinus rhythm (SR) throughout; 14 patients developed AF post operatively and 12
patients had established AF. Of these, 27 patients had normal left atrial diameters
(<4.5cm), 12 mild-moderate dilatation (4.5-5.5cm) and 8 moderate to severe dilatation
(>5.5cm). mRNA was extracted, purified and cDNA was synthesized using reverse tran-
scriptase. Real time relative quantification PCR was carried out. RESULTS: Our study
showed ubiquitous 'a' and variable 'b' isoform expression. The expression of the 'b' iso-
form increased and that of the 'a' isoform decreased with left atrial dilatation. This switch
correlated with post operative and established AF. CONCLUSION: Left atrial dilatation
modulates 5HT4 mRNA processing in favour of the 'b' isoform and this may not only pre-
dispose to AF post CABG but may also help perpetuate the arrhythmia. 
1034-213 A Carboxyl-Tailless Mutant of Connexin43 
Overexpressed in Transgenic Mice Reduces the pH 
Gating Sensitivity Between Atrial Myocytes
Nazem W. Akoum, Bilal Ali, Inayat Momin, Mansoor Anwer, Luis A. Aguirre, Alonso 
Moreno, Indiana University, Indianapolis, IN
Background: Gap junction channels play a significant role in the coordinated excitation
and contraction of the heart muscle. Myocardial ischemia compromises both contractile
and electrical excitability of cardiac tissue, setting the stage for deadly arrhythmias via
reentry mechanisms. Previous studies on oocytes have shown that during acidification,
coupling is preserved between cells expressing Cx43M257, a connexin43 mutant where
the carboxyl terminal has been truncated. To test the impact of this mutant on the gating
properties of other connexins, we examined changes in dye coupling from transgenic
atrial cells over-expressing this mutant.
Methods: Cx43M257 mutant gene was linked to the myosin heavy chain promoter. Iso-
lated adult atrial tissue was stretched over transparent chambers and bathed in zero cal-
cium solution. Lucifer yellow was microinjected for 5 min into single atrial cells from the
anterior wall every 5-10 min for 1 hr. Confocal scans were performed and the number of
coupled cells was determined after image reconstruction. Reduction of intracellular pH
(pHi) was achieved using 65 mM Na-acetate in the bath after 1-3 control injections.
Results: In control conditions, 3.5±1.37 cells were coupled (N=13). After 15±5 min of
acidification, the number of coupled cells in wild atria decreased to 2.00±0.50 (N=3).
Thereafter, cell coupling remained low for approximately 60 min (1.50±0.50). Cells from
transgenic mice remained coupled after 10±5 min (4.17±0.29) and 60 min (4.00±0.50) of
acidification (N=3).
Conclusion: Intercellular coupling is preserved between myocytes from atrial mice over-
expressing Cx43M257 during acidification. Our data suggest that Cx43M257 molecules
form heteromeric channels with other connexins, reducing their pHi gating sensitivity. If
intercellular communication is significantly preserved at low pHi, it may potentially
decrease the incidence of arrhythmias during ischemic episodes.
1034-214 Effects of Candesartan and Enalapril on Atrial 
Endocardial Nitric Oxide Synthase Expression in an 
Animal Model of Pacing Induced Atrial Remodelling
Fernando Cabestrero, Jose A. Cabrera, Elise Courtois, Jose M. Rubio, Miguel Orejas, 
Pedro P. Pérez, Ana B. Herrera, Antonio López-Farré, Jeronimo Farré, Fundacion 
Jimenez Diaz, Madrid, Spain
Has been recently demonstrated downregulation of endocardial Nitric Oxide Synthase
(eNOS) expression in an animal model of atrial fibrillation. Our study was designed to
assess the effects of enalapril and candesartan on atrial tissue eNOS expression in early
stages of atrial remodeling in a canine model of rapid atrial pacing.
Methods: Sixteen halothane-anesthetized adult beagle dogs underwent inserction of a
transvenous lead at the right atrial (RA) appendage. Twelve dogs were continuously
paced at 400 bpm for 3 days in presence of candesartan (4 dogs; 2mg/kg/day), enalapril
(4 dogs; 2 mg/kg/day) or without drugs (4 dogs). Four dogs served as control group. RA
effective refractory period (ERP) was measured baseline and after 3 days. RA tissue
eNOS expression was determined by Western-blot.
Results: After pacing, ERP was shorter (p=0.046) in untreated paced dogs than in con-
trols. Tisular eNOS expression in RA tissue was found in all dogs. RA tissue eNOS
expression decreased significantly (p=0.02) in paced dogs associated with an electro-
physiological remodeling. Both candesartan and enalapril prevented downregulation of
RA eNOS expression, however enalapril attenuated more significantly the effects on
ERP.
Conclusions: a) Pacing induced atrial remodeling is associated with an early downregula-
tion of atrial tissue eNOS expression; b) angiotensin-converting enzyme inhibitors pre-
vents the changes on atrial eNOs expression and the early atrial electrical remodeling.
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1035-215 Rate Control by Coupled Pacing During Atrial 
Fibrillation Increases Myocardial Efficiency
Don W. Wallick, Hirotsugu Yamada, Zoran B. Popovic, William J. Kowalewski, Neil L. 
Greenberg, David O. Martin, Cleveland Clinic Foundation, Cleveland, OH
Background: Paired stimulation is a powerful inotropic therapy. However, because it dra-
matically increases myocardial oxygen consumption (MVO2), this therapy has not been
apllied clinicaly. We previously demonstrated that coupled pacing (CP) significantly
reduced ventricular rate of mechanical contraction (VRMC) and increased contractility
during atrial fibrillation (AF). We hypothesize that reduction of the VRMC during CP will
minimize the increase of MVO2 and improve myocardial efficiency (MyoEf) during AF.
Methods: In 9 anesthetized dogs, we applied CP to the ventricles during sinus rhythm
(SR) and AF. Acute AF was induced and maintained by rapid atrial pacing. In order to
determine MyoEf, we calculated external cardiac power (ECP) = measured mean aortic
pressure (mAoP) X mean aortic flow (mAoF). MVO2 was calculated from measured coro-
nary sinus flow (CoF) X O2 extraction from coronary perfusion during SR and AF just
prior to and during CP (5 min periods). We defined myocardial efficiency as MyoEf =
ECP/MVO2. 
Results: 
Our CP increased MyoEf
 
during acute AF. In contrast, MyoEf decreased during SR.
Conclusions: The bradycardic effect of CP during AF probably minimized the marked 
elevation of MVO2 that had been previously observed during paired stimulation. Thus, 
CP may be a clinically useful pacing therapy for rate control during AF.
Right atrial electrical remodeling and eNOS expression
Control Paced-Untreated Paced-Candesartan Paced-Enalapril
ERP (day 3) 137±11.5 ms 80±30 ms 93±36 ms 142±22 ms
eNOS 100±14 % 67±16,5 % 97±18% 110±11,5%
VRMC
(/min)
mAoP
(mmHg)
mAoF
(L/min)
ECP
(watts)
MVO2
(ml/m)
MyoEf
(%)
SR 128±17 94±15 1.5±0.4 0.3±0.1 5.7±1.8 18±7
SR+CP 70±11 * 89±16* 1.5±0.4 0.3±0.1 6.9±2.4* 14±7*
AF 203±46 72±17 0.9±0.2 0.2±0.1 7.2±2.7 8±5
AF+CP 107±16 * 89±16* 1.4±0.1* 0.3±0.1* 8.7±3.3* 12±7 *
mean ± SD * p<0.05 comparing before and during CP
